Pelago

New York, United States Founded: 2014 • Age: 12 yrs
Personalized virtual clinic solutions for substance use disorders are provided.

About Pelago

Pelago is a Technology company based in New York (United States) founded in 2014 by Yusuf Sherwani, Sheeraz Iqbal, Sarim Siddiqui, and Maroof Ahmed. Personalized virtual clinic solutions for substance use disorders are provided. It operates on a HealthTech and Subscription Services model in Technology and Healthcare sectors. Pelago has raised $159.16 million across 9 funding rounds from investors including Merck, Syndicate Room and Triple Point. Its chief executive, as recorded, is Yusuf Sherwani. Its website pelagohealth.com draws about 70 thousand monthly visits. Pelago offers products and services including Substance Use Management, Alcohol Use Care, Tobacco Use Care, Opioid Use Care, and Cannabis Use Care. Its focus areas include Digital Health and Telehealth. Its competitors include Bicycle Health, Boulder Care and Monument; 3 of its 3 listed competitors have raised funding.

Company details

Pelago is established as a virtual clinic specializing in personalized substance use management. Services are provided for individuals seeking to manage or cease use of alcohol, tobacco, opioids, and cannabis. The approach is tailored based on individual health, habits, and goals, supported by physician-led care teams and evidence-based solutions. Sectors served include employers and health plans, with a focus on reducing healthcare costs and improving workforce productivity. Additional support is offered through remote monitoring, cognitive behavioral therapy, and medication-assisted treatment via PelagoRX. Access to high-quality inpatient facilities is coordinated for complex cases.

  • Headquarters New York, United States
  • Founders Yusuf Sherwani, Sheeraz Iqbal, Sarim Siddiqui, Maroof Ahmed
  • Sectors
    Technology
    Healthcare
  • Website category Business and Consumer Services · Marketing and Advertising
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website pelagohealth.com
  • Social LinkedIn X Facebook YouTube
  • Legal Name Pelago
Key Metrics
  • Total Equity Funding
    $159.16M (USD)

    in 9 rounds

  • Latest Funding Round
    $58M (USD), Series C

    Dec 2023

  • Investors
    Merck

    & 36 more

Products & Services of Pelago

Pelago offers a comprehensive portfolio of products and services, including Substance Use Management, Alcohol Use Care, Tobacco Use Care, Opioid Use Care, and Cannabis Use Care.

Substance Use Management
Healthcare

Personalized care for managing substance use is provided.

Alcohol Use Care
Healthcare

Support for reducing alcohol use is offered effectively.

Tobacco Use Care
Healthcare

Assistance in quitting tobacco use is delivered consistently.

Opioid Use Care
Healthcare

Care for achieving opioid abstinence is provided expertly.

Cannabis Use Care
Healthcare

Management of cannabis use issues is supported thoroughly.

Apps and channels of Pelago

its YouTube channel Pelago has 69 subscribers and 4 videos.

Pelago
YouTube 69 subscribers 4 videos Nonprofits & Activism
Open channel

Videos from Pelago

The most watched videos on Pelago's YouTube channel, Pelago (69 subscribers). Click a video to play it here.

Pelago Full Member Experience
809 views
We Are Pelago
551 views
Yusuf Sherwani, MD, CEO & Co-Founder
379 views
Pelago Member: Michael, GE Appliances
194 views

More on Pelago.

Funding Insights of Pelago

Pelago has successfully raised a total of $159.16M across 9 strategic funding rounds. The most recent funding activity was a Series C round of $58 million completed in December 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $159.16M
  • Total Rounds 9
  • Last Round Series C β€” $58M
  • First Round $1.3M

    (Feb 2018)

  • Investors Count 37

All 9 funding rounds of Pelago with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2023$58MSeries C–Atomico
Jul 2022$11.5MSeries B––
–
Jul 2021$64MSeries B–Kinnevik, Atomico
Mar 2020$11MSeries A–Octopus Ventures
Jan 2020$12.14MSeries B––
–
Jun 2018$125,000Seed––
Jun 2018Seed––
May 2018$1.1MSeed–Village Global, Pioneer Fund
Feb 2018$1.3MSeed–Wayra
Valuation history

37 investors in total: 18 institutional and 19 angel.

Investors in Pelago

Pelago has secured backing from 37 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Merck, Syndicate Room and Triple Point.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Tech-based companies are invested in by Atomico venture capital fund.
2006atomico.comLondon, United Kingdom
Venture capital investments are directed toward multiple sectors by Kinnevik.
1936kinnevik.comStockholm, Sweden
Venture capital investment and support for founders in technology and health sectors.
octopusventures.com
Early-stage startups are accelerated via funding and educational programs.
ycombinator.comMountain View, United States
Venture capital investment and global platform support for startups.
2008eightroads.comLondon, United Kingdom
GreyMatter is focused on investing in mental health innovation.
greymattercapital.com
Online information platform of health and wellness
2011startuphealth.comSan Francisco, United States
Provider of investment management services
2004triplepoint.co.ukLondon, United Kingdom
Investments are made in early-stage startups by Serena Ventures.
serenaventures.comSan Francisco, United States
Early-stage venture capital investing, network building, and founder support services.
villageglobal.vc
Premium access

Investor details for Pelago

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Pelago

6 people are tracked at Pelago (6 in leadership).

NameRoleGroup
Ricky So
Chief Commercial OfficerLeadership
Yusuf Sherwani
Co-Founder & CEOLeadership
Sheeraz Iqbal
Co-FounderLeadership
Sarim Siddiqui
Co-FounderLeadership
Maroof Ahmed
Co-Founder & COOLeadership
Jeffrey Cheung
Director FinanceLeadership
Premium access

Complete people profiles for Pelago

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Pelago

3 dated milestones of Pelago across 9 years, from founding to its latest funding, stage changes and deals.

  1. Founded Pelago is founded.
  2. Funding First funding round of $1.3M.
  3. Funding Latest funding round, Series C, of $58.0M.

Competitors of Pelago

Pelago has 3 listed competitors in our database, 3 of them funded. They include Bicycle Health, Boulder Care and Monument.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
bicyclehealth.com2018San Francisco, United States$104M258
An online platform is provided for deaddiction doctor consultations.
boulder.care2017Brooklyn, United States$82.46M74
Telehealth-based treatment for substance use disorders is provided.
joinmonument.com2019New York, United States$23.61M
SaaS telehealth platform for de-addiction support is provided.
Premium access

Detailed competitors of Pelago

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Pelago

The website of Pelago (pelagohealth.com) receives about 69.9K visits a month and ranks #555,398 among all websites worldwide, #2,460 in Marketing and Advertising.

  • Monthly visits
    69.9K

    ▲ 10.7% vs previous month

  • Unique visitors
    25.7K

    per month

  • Global rank
    #555,398

    among all websites

  • Category rank
    #2,460

    Business and Consumer Services · Marketing and Advertising

Similar websites

Websites whose visitors overlap most with Pelago. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
mindtools.com
100%
445.7K#133,318View details

Top companies in HR & Workforce Technology

3 companies that operate in the same segment as Pelago (HR & Workforce Technology) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Anonymous employee reviews and job search platform are operated.
2007San Francisco, California, United StatesUSD 201.5 M1,695
Cloud-based LMS platform for IT industry
2004Farmington, Utah, United StatesUSD 235.41 MUSD 4.95 M1,774
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Pelago

Premium access

Complete news archive for Pelago

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pelago

Pelago was founded in 2014 and raised its 1st funding round 4 years after it was founded.

Pelago is headquartered in New York, United States. It is registered at New York, New York, United States.

Yusuf Sherwani is the CEO of Pelago, as recorded in our data. They have also founded this company.

Pelago is a funded company, having raised a total of $159.16M across 9 funding rounds to date. The company's 1st funding round was a Seed of $1.3M, raised on Feb 2018.

Pelago is established as a virtual clinic specializing in personalized substance use management. Services are provided for individuals seeking to manage or cease use of alcohol, tobacco, opioids, and cannabis. The approach is tailored based on individual health, habits, and goals, supported by physician-led care teams and evidence-based solutions. Sectors served include employers and health plans, with a focus on reducing healthcare costs and improving workforce productivity. Additional support is offered through remote monitoring, cognitive behavioral therapy, and medication-assisted treatment via PelagoRX. Access to high-quality inpatient facilities is coordinated for complex cases.

Pelago's top competitors include Bicycle Health, Boulder Care and Monument.

Pelago offers Substance Use Management, Alcohol Use Care, Tobacco Use Care, Opioid Use Care, and Cannabis Use Care.

Pelago has 37 investors. Key investors include Merck, Syndicate Room, Triple Point, Atomico, and Kinnevik.

Pelago operates through Pelago.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available